-+ 0.00%
-+ 0.00%
-+ 0.00%

GALECTIN THERAPEUTICS SHARES FALL 50% PREMARKET AFTER LIVER DISEASE DRUG FAILS TO MEET MAIN GOAL IN STUDY

Reuters·12/20/2024 13:15:57

Please log in to view news